Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Sep 13, 2016 $7.12 $7.20 $6.87 $6.94 650 600
Sep 12, 2016 $7.01 $7.28 $6.80 $7.22 1 070 500
Sep 09, 2016 $7.66 $7.66 $7.13 $7.16 829 100
Sep 08, 2016 $7.24 $7.75 $7.24 $7.65 873 600
Sep 07, 2016 $7.20 $7.36 $7.10 $7.34 550 400
Sep 06, 2016 $7.09 $7.37 $7.09 $7.16 528 100
Sep 02, 2016 $7.12 $7.32 $7.01 $7.15 500 900
Sep 01, 2016 $6.85 $7.08 $6.83 $7.06 465 700
Aug 31, 2016 $7.03 $7.13 $6.73 $6.93 922 300
Aug 30, 2016 $6.83 $7.47 $6.83 $7.08 1 073 700
Aug 29, 2016 $6.83 $6.95 $6.60 $6.89 765 800
Aug 26, 2016 $6.87 $7.11 $6.82 $6.95 735 300
Aug 25, 2016 $6.95 $7.30 $6.70 $6.88 1 281 100
Aug 24, 2016 $8.20 $8.22 $6.68 $6.89 3 080 700
Aug 23, 2016 $7.83 $8.22 $7.82 $8.08 1 589 700
Aug 22, 2016 $7.58 $8.00 $7.40 $7.75 1 314 200
Aug 19, 2016 $7.14 $7.73 $7.00 $7.50 2 230 800
Aug 18, 2016 $6.67 $7.20 $6.60 $7.06 3 042 300
Aug 17, 2016 $6.14 $6.35 $6.09 $6.34 537 900
Aug 16, 2016 $6.08 $6.30 $6.07 $6.17 642 800
Aug 15, 2016 $5.93 $6.18 $5.93 $6.12 650 200
Aug 12, 2016 $5.72 $6.03 $5.68 $5.96 546 200
Aug 11, 2016 $5.83 $5.85 $5.68 $5.74 426 600
Aug 10, 2016 $5.92 $6.00 $5.61 $5.83 1 132 100
Aug 09, 2016 $5.86 $6.44 $5.50 $6.39 1 992 400
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT